[Press release – not published yet] Merck announces oral antiv | Critical Care & Emergencies

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

https://www.linksmedicus.com/news/press-release-not-published-yet-merck-announces-oral-antiviral-molnupiravir-reduced-risk-hospitalization-death-approximately-50-percent-compared-placebo-patients-m/